| NCT ID | NCT06036693 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut National de la Santé Et de la Recherche Médicale, France |
| Condition | Mucopolysaccharidosis I |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2017-12-20 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2017-12-20 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to characterize the epidemiology and natural history of MPS diseases by building a retrospective and prospective collection of extensive phenotypic data from French MPS patients.
Eligibility Criteria
Inclusion Criteria: * Confirmed diagnosis of MPS based on clinically relevant enzyme deficiency, with abnormally elevated GAG urinary excretion and/or identification of pathogenic mutations. * Signed informed consent or parents/guardian non-opposition for deceased patients (minor or protected major) There are no non-inclusion criteria.
Contact & Investigator
Thierry BILLETTE DE VILLEMEUR
PRINCIPAL INVESTIGATOR
INSERM UMR 1141
Frequently Asked Questions
Who can join the NCT06036693 clinical trial?
This trial is open to participants of all sexes, studying Mucopolysaccharidosis I. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06036693 currently recruiting?
Yes, NCT06036693 is actively recruiting participants. Contact the research team at benedicte.heron@aphp.fr for enrollment information.
Where is the NCT06036693 trial being conducted?
This trial is being conducted at Angers, France, Bordeaux, France, Brest, France, Clermont-Ferrand, France and 11 additional locations.
Who is sponsoring the NCT06036693 clinical trial?
NCT06036693 is sponsored by Institut National de la Santé Et de la Recherche Médicale, France. The principal investigator is Thierry BILLETTE DE VILLEMEUR at INSERM UMR 1141. The trial plans to enroll 1,000 participants.